跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 247 条关于
“Mucopolysaccharidosis”
全部
247
临床试验
188
药物
12
机构
0
资讯
47
2年前
JCR Pharmaceuticals' JR-441 Receives Clearance for Phase I MPS IIIA Trial in Japan
去年
Regenxbio Expands MPS I Gene Therapy Trial After Initial Data Review
去年
Immusoft's Engineered B Cell Therapy Shows Promise in Phase 1 MPS I Trial
去年
REGENXBIO and Nippon Shinyaku Partner to Advance Gene Therapies for MPS I and MPS II
9个月前
Immusoft Receives FDA Orphan Drug Designation for Engineered B Cell Therapy ISP-002 in Hunter Syndrome
去年
Immusoft Reports Breakthrough Results from First-Ever Engineered B Cell Therapy in MPS I Clinical Trial
去年
FDA Grants Orphan Drug Designation to JR-446 for Rare Neurological Disorder MPS IIIB
2年前
JCR Pharmaceuticals' Laronidase for Hurler Syndrome Expected to Generate $38M by 2040
去年
Orchard Therapeutics' Lenmeldy Shows Long-Term Efficacy in Treating Metachromatic Leukodystrophy, NEJM Study Reveals
去年
CDSCO Panel Approves Label Updates for Sanofi's Rare Disease Therapies Fabrazyme and Aldurazyme
第 1 页,共 5 页
上一页
下一页